Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...
Clascoterone will be the first ever drug in 30 years to treat male pattern baldness by boosting hair growth by 500% ...
New 2025 study results show Clascoterone, originally approved for acne, could be the first new effective topical for male ...
SUZHOU, China, March 21, 2023 /PRNewswire/ -- The 2023 Annual Meeting of American Academy of Dermatology Association (AAD 2023) was held from 17 to 21 March 2023 in New Orleans, Louisiana, United ...
SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological ...
Please provide your email address to receive an email when new articles are posted on . At week 24, 17% to 28% of adolescents treated with ritlecitinib 30 mg and higher achieved the primary endpoint.
Younger patients with alopecia areata (AA) and those who have a history of acne were more likely to develop acne during Janus kinase inhibitor (JAKi) treatment in a study. Researchers conducted a ...
Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a phase 3 trial for severe alopecia ...
'Riverdale' actress Lili Reinhard has revealed she was diagnosed with Alopecia while in the midst of a "major depressive episode." The 27-year-old actress posted a TikTok video where she opened up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback